AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglibose M 500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Indizen Pharmaceutical

Salt Composition

Metformin (500mg) + Vildagliptin (0.2mg)

Overview Voglibose M 500mg/0.2mg Tablet

Combiflox 500mg/0.2mg tablets manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action helps mitigate serious diabetic complications like vision loss and kidney impairment, potentially lessening heart attack and stroke risks. Combiflox may be used alone or in conjunction with other anti-diabetic therapies. Optimal results require adherence to a prescribed diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and other medications. Consuming the tablet with meals minimizes digestive discomfort. Consistent, daily dosing maximizes effectiveness; discontinuation should only occur under medical supervision. Effective blood sugar control prevents future complications. Maintaining the recommended diet and exercise regimen is crucial. Lifestyle choices significantly influence diabetes management. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage it. Consult your physician prior to use if you have pre-existing kidney, liver, or heart conditions, pancreatic issues, or consume excessive alcohol. Pregnant or lactating individuals should seek medical advice. Inform your doctor of all medications you are taking to ensure compatibility and safety. Alcohol consumption should be minimized due to its hypoglycemic effects. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Uses of Voglibose M 500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Voglibose M 500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 500mg/0.2mg Voglibose M tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with meals.

Common Side effects of Voglibose M 500mg/0.2mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Voglibose M 500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 500mg/0.2mg Voglibose M tablet whole; avoid chewing, crushing, or fracturing it. Administration should coincide with mealtimes.

How Voglibose M 500mg/0.2mg Tablet works:

Each Voglibose M 500mg/0.2mg tablet contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglibose M 500mg/0.2mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Voglibose M 500mg/0.2mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Voglibose M 500mg/0.2mg tablets is potentially unsafe. Available evidence from human studies indicates a risk of the medication transferring to breast milk, potentially harming the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney disease should use Voglibose M 500mg/0.2mg Tablets cautiously, as dose modification may be necessary. A physician's consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Voglibose M 500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Voglibose M 500mg/0.2mg Tablet :

Should you forget a Voglibose M 500mg/0.2mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglibose M 500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglibose M 500mg/0.2mg Tablet

Voglibose M 500mg/0.2mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Voglibose M 500mg/0.2mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Patients with allergies to Voglibose M 500mg/0.2mg Tablet components or excipients should not use it. This medication is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglibose M 500mg/0.2mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA when associated with metformin), is a rare but potential side effect of Voglibose M 500mg/0.2mg Tablet. This risk is heightened in patients with kidney disease, the elderly, and those who consume excessive alcohol, hence its avoidance in these groups. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should you experience any of these, discontinue Voglibose M 500mg/0.2mg Tablet and seek immediate medical attention.
Prolonged use of Voglibose M 500mg/0.2mg Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Voglibose M 500mg/0.2mg tablets are safe when used as directed by your doctor. However, even with proper use, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (especially when combined with insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Voglibose M 500mg/0.2mg T...
70
MRP 85
17% off